We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$5.39B
AUM Growth
+$665M
Cap. Flow
+$578M
Cap. Flow %
10.73%
Top 10 Hldgs %
20.55%
Holding
1,844
New
287
Increased
821
Reduced
564
Closed
102

Sector Composition

Rank Sector Weight
1 Technology 4.52%
2 Healthcare 4.34%
3 Financials 4.33%
4 Industrials 4.29%
5 Consumer Staples 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
1701
Lineage Cell Therapeutics
LCTX
$283M
$48K ﹤0.01%
+14,122
New +$39K
ACGN
1702
DELISTED
Aceragen Inc
ACGN
$46K ﹤0.01%
132
AXAS
1703
DELISTED
Abraxas Petroleum Corp
AXAS
$44K ﹤0.01%
+1,300
New +$35.4K
MVIS icon
1704
Microvision
MVIS
$86.6M
$42K ﹤0.01%
2,008
-2
-0.1% -$47
AMPE
1705
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$41K ﹤0.01%
+182
New +$51K
AMRN
1706
Amarin Corp
AMRN
$296M
$40K ﹤0.01%
+623
New +$34.9K
TLPH icon
1707
Talphera
TLPH
$76.3M
$40K ﹤0.01%
+515
New +$34.2K
SDLP
1708
DELISTED
SEADRILL PARTNERS LLC
SDLP
$40K ﹤0.01%
1,136
PER
1709
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$34K ﹤0.01%
+11,956
New +$31.3K
PRPO icon
1710
Precipio
PRPO
$39.9M
$32K ﹤0.01%
13
PGH
1711
DELISTED
Pengrowth Energy Corporation
PGH
$31K ﹤0.01%
19,210
+1
+0% +$2
XXII
1712
22nd Century Group
XXII
$1.52M
0
ORKA
1713
Oruka Therapeutics
ORKA
$6.93B
$30K ﹤0.01%
48
CRNT icon
1714
Ceragon Networks
CRNT
$199M
$28K ﹤0.01%
11,735
+1,485
+14% +$3.4K
PLM
1715
DELISTED
PolyMet Mining Corp.
PLM
$27K ﹤0.01%
3,419
ZN
1716
DELISTED
Zion Oil & Gas, Inc.
ZN
$24K ﹤0.01%
17,251
-1,400
-8% -$1.95K
GERN icon
1717
Geron
GERN
$1.05B
$23K ﹤0.01%
10,025
-11,530
-53% -$29.9K
QMCO icon
1718
Quantum Corp
QMCO
$765M
$23K ﹤0.01%
193
ASXC
1719
DELISTED
Asensus Surgical, Inc.
ASXC
$22K ﹤0.01%
+992
New +$18.1K
NAVB
1720
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$22K ﹤0.01%
1,188
+350
+42% +$4.43K
HEPA
1721
DELISTED
Hepion Pharmaceuticals
HEPA
0
EGY icon
1722
Vaalco Energy
EGY
$609M
$19K ﹤0.01%
20,130
HHS icon
1723
Harte-Hanks
HHS
$18.5M
$19K ﹤0.01%
+1,200
New +$19.8K
XTNT icon
1724
Xtant Medical Holdings
XTNT
$44.9M
$18K ﹤0.01%
1,350
PTX
1725
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$17K ﹤0.01%
2,800
+100
+4% +$616

Similar funds

Cambridge Investment Research Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Cambridge Investment Research Advisors held 1,844 positions worth $5.39B, up 14% from $4.72B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $578M of net new capital in Q3 2016, opening 287 new positions and adding to 821 existing holdings. Its largest new stake was Apple: 3,414,476 shares worth $96.5M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, up from 2.4% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF, an estimated $16.4M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2016 buy was Apple: 3,414,476 shares worth $96.5M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2016, an estimated $31.1M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2016 reduction was First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF, cutting an estimated $16.4M.
  • Cambridge Investment Research Advisors fully exited Walt Disney in Q3 2016, selling an estimated $19.1M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $5.39B portfolio in Q3 2016.
  • Cambridge Investment Research Advisors opened 287 new positions and closed 102 in Q3 2016.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $5.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.